Loading...
XNASNAYA
Market cap3mUSD
Jan 08, Last price  
0.86USD
1D
-10.42%
1Q
26.01%
Jan 2017
-99.35%
IPO
-99.88%
Name

INVO Bioscience Inc

Chart & Performance

D1W1MN
XNAS:NAYA chart
P/E
—
P/S
1.11
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
45.39%
Rev. gr., 5y
43.62%
Revenues
3m
+267.38%
0037,99563,20467,64871,50356,37727,06316,58811,68950,901282,145494,3751,480,2131,037,2864,160,116822,1963,020,575
Net income
-8m
L-26.24%
-7,386-43,386-1,873,405-4,661,469-153,430-797,471-666,454-760,679-1,732,472-4,959,247-2,124,252-702,163-3,076,091-2,167,544-8,347,316-6,654,940-10,892,511-8,034,612
CFO
-5m
L-27.99%
-1,011-12,941-1,066,629-926,664-315,992-117,779-43,209-59,916-19,401-151,622-323,900-181,270-652,9711,370,513-4,775,148-6,029,914-6,603,319-4,755,054
Earnings
May 13, 2025

Profile

INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.
URL
https://invobioscience.com/
IPO date
Nov 11, 2008
Employees
15
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
3,021
267.38%
822
-80.24%
Cost of revenue
2,100
876
Unusual Expense (Income)
NOPBT
920
(53)
NOPBT Margin
30.46%
Operating Taxes
28
3
Tax Rate
3.02%
NOPAT
892
(56)
Net income
(8,035)
-26.24%
(10,893)
63.68%
Dividends
Dividend yield
Proceeds from repurchase of equity
5,702
290
BB yield
-269.72%
-5.64%
Debt
Debt current
1,907
994
Long-term debt
12,696
3,572
Deferred revenue
(2)
Other long-term liabilities
5,000
2
Net debt
11,283
3,238
Cash flow
Cash from operating activities
(4,755)
(6,603)
CAPEX
(445)
(13)
Cash from investing activities
(2,495)
(81)
Cash from financing activities
7,392
1,090
FCF
(173)
2,032
Balance
Cash
232
90
Long term investments
3,088
1,238
Excess cash
3,170
1,287
Stockholders' equity
(57,818)
(49,782)
Invested Capital
72,394
51,469
ROIC
1.44%
ROCE
6.31%
EV
Common stock shares outstanding
1,566
606
Price
1.35
-84.07%
8.48
-87.27%
Market cap
2,114
-58.85%
5,138
-85.49%
EV
19,397
8,375
EBITDA
1,121
253
EV/EBITDA
17.30
33.11
Interest
926
59
Interest/NOPBT
100.62%